TY - JOUR
T1 - Salter-Harris type II fractures of the distal tibia Residual postreduction displacement and outcomes - A STROBE compliant study
AU - Margalit, Adam
AU - Peddada, Kranti V.
AU - Dunham, Alexandra M.
AU - Remenapp, Craig M.
AU - Lee, R. Jay
N1 - Publisher Copyright:
© 2020 the Author(s). Published by Wolters Kluwer Health, Inc.
PY - 2020
Y1 - 2020
N2 - We assessed factors associated with premature physeal closure (PPC) and outcomes after closed reduction of Salter-Harris type II (SH-II) fractures of the distal tibia. We reviewed patients with SH-II fractures of the distal tibia treated at our center from 2010 to 2015 with closed reduction and a non-weightbearing long-leg cast. Patients were categorized by immediate postreduction displacement: minimal, <2mm; moderate, 2 to 4mm; or severe, >4mm. Demographic data, radiographic data, and Lower Extremity Functional Scale (LEFS) scores were recorded.Fifty-nine patients (27 girls, 31 right ankles, 26 concomitant fibula fractures) were included, with a mean (±SD) age at injury of 12.0±2.2 years. Mean maximum fracture displacements were 6.6±6.5mm initially, 2.7±2.0mm postreduction, and 0.4±0.7mm at final follow-up. After reduction, displacement was minimal in 23 patients, moderate in 21, and severe in 15. Fourteen patients developed PPC, with no significant differences between postreduction displacement groups. Patients with high-grade injury mechanisms and/or initial displacement ≥4mm had 12-fold and 14-fold greater odds, respectively, of PPC. Eighteen patients responded to the LEFS survey (mean 4.0±2.1 years after injury). LEFS scores did not differ significantly between postreduction displacement groups (P=.61).The PPC rate in this series of SH-II distal tibia fractures was 24% and did not differ by postreduction displacement. Initial fracture displacement and high-grade mechanisms of injury were associated with PPC. LEFS scores did not differ significantly by postreduction displacement.Level of Evidence: Level IV, case series.
AB - We assessed factors associated with premature physeal closure (PPC) and outcomes after closed reduction of Salter-Harris type II (SH-II) fractures of the distal tibia. We reviewed patients with SH-II fractures of the distal tibia treated at our center from 2010 to 2015 with closed reduction and a non-weightbearing long-leg cast. Patients were categorized by immediate postreduction displacement: minimal, <2mm; moderate, 2 to 4mm; or severe, >4mm. Demographic data, radiographic data, and Lower Extremity Functional Scale (LEFS) scores were recorded.Fifty-nine patients (27 girls, 31 right ankles, 26 concomitant fibula fractures) were included, with a mean (±SD) age at injury of 12.0±2.2 years. Mean maximum fracture displacements were 6.6±6.5mm initially, 2.7±2.0mm postreduction, and 0.4±0.7mm at final follow-up. After reduction, displacement was minimal in 23 patients, moderate in 21, and severe in 15. Fourteen patients developed PPC, with no significant differences between postreduction displacement groups. Patients with high-grade injury mechanisms and/or initial displacement ≥4mm had 12-fold and 14-fold greater odds, respectively, of PPC. Eighteen patients responded to the LEFS survey (mean 4.0±2.1 years after injury). LEFS scores did not differ significantly between postreduction displacement groups (P=.61).The PPC rate in this series of SH-II distal tibia fractures was 24% and did not differ by postreduction displacement. Initial fracture displacement and high-grade mechanisms of injury were associated with PPC. LEFS scores did not differ significantly by postreduction displacement.Level of Evidence: Level IV, case series.
KW - Salter-Harris type II fracture
KW - distal tibia fracture
KW - nonoperative treatment
KW - postreduction fracture displacement
KW - premature physeal closure
UR - http://www.scopus.com/inward/record.url?scp=85080032645&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85080032645&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000019328
DO - 10.1097/MD.0000000000019328
M3 - Article
C2 - 32118764
AN - SCOPUS:85080032645
SN - 0025-7974
VL - 99
JO - Medicine (United States)
JF - Medicine (United States)
IS - 9
M1 - e19328
ER -